Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 132

1.

Generation of functional human hepatocytes in vitro: current status and future prospects.

Yamaguchi T, Matsuzaki J, Katsuda T, Saito Y, Saito H, Ochiya T.

Inflamm Regen. 2019 Jul 2;39:13. doi: 10.1186/s41232-019-0102-4. eCollection 2019. Review.

2.

Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.

Saito Y, Muramatsu T, Kanai Y, Ojima H, Sukeda A, Hiraoka N, Arai E, Sugiyama Y, Matsuzaki J, Uchida R, Yoshikawa N, Furukawa R, Saito H.

Cell Rep. 2019 Apr 23;27(4):1265-1276.e4. doi: 10.1016/j.celrep.2019.03.088.

3.

Erratum: Publisher Correction: Epigenetic silencing of Lgr5 induces senescence of intestinal epithelial organoids during the process of aging.

Uchida R, Saito Y, Nogami K, Kajiyama Y, Suzuki Y, Kawase Y, Nakaoka T, Muramatsu T, Kimura M, Saito H.

NPJ Aging Mech Dis. 2019 Mar 7;5:5. doi: 10.1038/s41514-019-0035-9. eCollection 2019.

4.

Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori.

Saito Y, Konno K, Sato M, Nakano M, Kato Y, Saito H, Serizawa H.

Cancers (Basel). 2019 Jan 19;11(1). pii: E116. doi: 10.3390/cancers11010116.

5.

Epigenetic silencing of Lgr5 induces senescence of intestinal epithelial organoids during the process of aging.

Uchida R, Saito Y, Nogami K, Kajiyama Y, Suzuki Y, Kawase Y, Nakaoka T, Muramatsu T, Kimura M, Saito H.

NPJ Aging Mech Dis. 2018 Dec 1;5:1. doi: 10.1038/s41514-018-0031-5. eCollection 2019. Erratum in: NPJ Aging Mech Dis. 2019 Mar 7;5:5.

6.

Liver Fibrosis Markers Improve Prediction of Outcome in Non-Acetaminophen-Associated Acute Liver Failure.

Ugamura A, Chu PS, Nakamoto N, Taniki N, Ojiro K, Hibi T, Shinoda M, Obara H, Masugi Y, Yamaguchi A, Shiba S, Morikawa R, Usui S, Ebinuma H, Kitagawa Y, Saito H, Kanai T.

Hepatol Commun. 2018 Sep 21;2(11):1331-1343. doi: 10.1002/hep4.1233. eCollection 2018 Nov.

7.

Nrf2-mediated anti-oxidant effects contribute to suppression of non-alcoholic steatohepatitis-associated hepatocellular carcinoma in murine model.

Yamada S, Kimura M, Saito Y, Saito H.

J Clin Biochem Nutr. 2018 Sep;63(2):123-128. doi: 10.3164/jcbn.17-125. Epub 2018 Apr 3.

8.

Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells.

Murakami Y, Sugiyama K, Ebinuma H, Nakamoto N, Ojiro K, Chu PS, Taniki N, Saito Y, Teratani T, Koda Y, Suzuki T, Saito K, Fukasawa M, Ikeda M, Kato N, Kanai T, Saito H.

BMC Cancer. 2018 Jun 25;18(1):680. doi: 10.1186/s12885-018-4588-y.

9.

Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice.

Yamada S, Takashina Y, Watanabe M, Nagamine R, Saito Y, Kamada N, Saito H.

Oncotarget. 2018 Jan 6;9(11):9925-9939. doi: 10.18632/oncotarget.24066. eCollection 2018 Feb 9.

10.

Induction of differentiation of intrahepatic cholangiocarcinoma cells to functional hepatocytes using an organoid culture system.

Saito Y, Nakaoka T, Muramatsu T, Ojima H, Sukeda A, Sugiyama Y, Uchida R, Furukawa R, Kitahara A, Sato T, Kanai Y, Saito H.

Sci Rep. 2018 Feb 12;8(1):2821. doi: 10.1038/s41598-018-21121-6.

11.

Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis.

Yamada S, Kamada N, Amiya T, Nakamoto N, Nakaoka T, Kimura M, Saito Y, Ejima C, Kanai T, Saito H.

BMC Gastroenterol. 2017 Nov 29;17(1):136. doi: 10.1186/s12876-017-0689-3.

12.

Commensal Lactobacillus Controls Immune Tolerance during Acute Liver Injury in Mice.

Nakamoto N, Amiya T, Aoki R, Taniki N, Koda Y, Miyamoto K, Teratani T, Suzuki T, Chiba S, Chu PS, Hayashi A, Yamaguchi A, Shiba S, Miyake R, Katayama T, Suda W, Mikami Y, Kamada N, Ebinuma H, Saito H, Hattori M, Kanai T.

Cell Rep. 2017 Oct 31;21(5):1215-1226. doi: 10.1016/j.celrep.2017.10.022.

13.

Detection of bacterial DNA by in situ hybridization in patients with decompensated liver cirrhosis.

Usui S, Ebinuma H, Chu PS, Nakamoto N, Yamagishi Y, Saito H, Kanai T.

BMC Gastroenterol. 2017 Oct 17;17(1):106. doi: 10.1186/s12876-017-0664-z.

14.

On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C.

Chu PS, Nakamoto N, Taniki N, Ojiro K, Amiya T, Makita Y, Murata H, Yamaguchi A, Shiba S, Miyake R, Katayama T, Ugamura A, Ikura A, Takeda K, Ebinuma H, Saito H, Kanai T.

PLoS One. 2017 Jun 15;12(6):e0179096. doi: 10.1371/journal.pone.0179096. eCollection 2017.

15.

Free cholesterol accumulation in liver sinusoidal endothelial cells exacerbates acetaminophen hepatotoxicity via TLR9 signaling.

Teratani T, Tomita K, Suzuki T, Furuhashi H, Irie R, Hida S, Okada Y, Kurihara C, Ebinuma H, Nakamoto N, Saito H, Hibi T, Miura S, Hokari R, Kanai T.

J Hepatol. 2017 Oct;67(4):780-790. doi: 10.1016/j.jhep.2017.05.020. Epub 2017 May 26.

PMID:
28554874
16.

Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma.

Nakaoka T, Saito Y, Saito H.

Int J Mol Sci. 2017 May 23;18(6). pii: E1111. doi: 10.3390/ijms18061111. Review.

17.

Cluster microRNAs miR-194 and miR-215 suppress the tumorigenicity of intestinal tumor organoids.

Nakaoka T, Saito Y, Shimamoto Y, Muramatsu T, Kimura M, Kanai Y, Saito H.

Cancer Sci. 2017 Apr;108(4):678-684. doi: 10.1111/cas.13165. Epub 2017 Apr 19.

18.

microRNA-mediated resistance to hypoglycemia in the HepG2 human hepatoma cell line.

Ueki S, Murakami Y, Yamada S, Kimura M, Saito Y, Saito H.

BMC Cancer. 2016 Sep 15;16(1):732. doi: 10.1186/s12885-016-2762-7.

19.

Diagnosing native liver fibrosis and esophageal varices using liver and spleen stiffness measurements in biliary atresia: a pilot study.

Tomita H, Ohkuma K, Masugi Y, Hosoe N, Hoshino K, Fuchimoto Y, Fujino A, Shimizu T, Kato M, Fujimura T, Ishihama H, Takahashi N, Tanami Y, Ebinuma H, Saito H, Sakamoto M, Nakano M, Kuroda T.

Pediatr Radiol. 2016 Sep;46(10):1409-17. doi: 10.1007/s00247-016-3637-4. Epub 2016 Jun 14.

PMID:
27300741
20.

Evidence-based clinical practice guidelines for liver cirrhosis 2015.

Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I, Shibuya A, Seike M, Nagoshi S, Segawa M, Tsubouchi H, Moriwaki H, Kato A, Hashimoto E, Michitaka K, Murawaki T, Sugano K, Watanabe M, Shimosegawa T.

J Gastroenterol. 2016 Jul;51(7):629-50. doi: 10.1007/s00535-016-1216-y. Epub 2016 May 31. Review.

PMID:
27246107

Supplemental Content

Loading ...
Support Center